Levetiracetam-Mepha 250 mg
Levetiracetam-Mepha 250 mg is a medicine authorised by Swissmedic under authorisation number 61651. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 September 2011 and the authorisation is valid without a time limit. ATC code N03AX14 places the medicine in the group Antiepileptics.
| Authorisation number | 61651 |
|---|---|
| Name | Levetiracetam-Mepha 250 mg |
| Full name | Levetiracetam-Mepha 250 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AX14 |
| First authorisation | 08 September 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Levetiracetam-Mepha 250 mg, Filmtabletten | B | 08 September 2011 |
| 2 | Levetiracetam-Mepha 500 mg, Filmtabletten | B | 08 September 2011 |
| 4 | Levetiracetam-Mepha 1000 mg, Filmtabletten | B | 08 September 2011 |
| 5 | Levetiracetam-Mepha 750 mg, Filmtabletten | B | 21 June 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 17 | 30 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 18 | 20 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 19 | 100 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 20 | 200 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 21 | 30 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 22 | 100 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 23 | 200 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 24 | 30 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 25 | 100 | Tablette(n) | N03AX14 | 01.07.1. | B |
| 26 | 200 | Tablette(n) | N03AX14 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Levetiracetam-Mepha 250 mg authorised in Switzerland?
Yes. Levetiracetam-Mepha 250 mg is authorised by Swissmedic under authorisation number 61651, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Levetiracetam-Mepha 250 mg have?
Levetiracetam-Mepha 250 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Levetiracetam-Mepha 250 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.